Management of malignant mesothelioma by decortication and adjunct phototherapy

Asian Cardiovascular and Thoracic Annals

Volumn 14, Issue 3, 2006, Pages 206-209

  Clarke, Charles P ^a,b   Knight, Simon R ^a   Daniel, Freddy J ^a   Seevanayagam, Siven ^a  

^a AUSTIN HEALTH   (Australia)

^b NONE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ASBESTOS; CISPLATIN DERIVATIVE; HEMATOPORPHYRIN DERIVATIVE;

ADULT; AGED; APPLICATION SITE BURNING; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENVIRONMENTAL EXPOSURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT MESOTHELIOMA; MORTALITY; PHOTOTHERAPY; PNEUMONIA; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; SURVIVAL TIME; TREATMENT OUTCOME;

EID: 33745046615     PISSN: 02184923     EISSN: None     Source Type: Journal    
DOI: 10.1177/021849230601400307     Document Type: Article

References (19)

1. Antman KH. Clinical presentation and natural history of benign and malignant mesothelioma. Semin Oncol 1981;8:313-20.
2. Aziz T, Jilaihawi A, Prakash D. The management of malignant pleural mesothelioma: single centre experience in 10 years. Eur J Cardio-thorac Surg 2002;22:298-305.
3. Ball DL, Cruickshank DG. The treatment of malignant mesothelioma of the pleura: review of a 5-year experience, with special reference to radiotherapy. Am J Clin Oncol 1990;13:4-9.
4. Cugell DW, Kamp DW. Asbestos and the pleura: a review. Chest 2004;125:1103-17.
5. Law MR, Gregor A, Hodson ME, Bloom HJ, Turner-Warwick M. Malignant mesothelioma of the pleura: a study of 52 treated: 64 untreated patients. Thorax 1984;39:255-9.
6. Merritt N, Blewett CJ, Miller JD, Bennett WF, Young JE, Urschel JD. Survival after conservative (palliative) management of pleural malignant mesothelioma. J Surg Oncol 2001;78:171-4.
7. Rusch VW. A proposed new international staging system for malignant pleural mesothelioma: from the International Mesothelioma Interest Group. Chest 1995;108:1122-8.
8. Moskal TL, Dougherty TJ, Urschel JD, Antkowiak JG, Regal AM, Driscoll D, et al. Operation and photodynamic therapy for pleural mesothelioma: 6-year follow-up. Ann Thorac Surg 1988;66:1128-33.
9. Pass HI, Pogrebniak H. Photodynamic therapy for thoracic malignancies. Semin Surg Oncol 1992;8:217-25.
10. Wagner JC, Sleggs CA, Marchand P. Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Provence. Br J Ind Med 1960;17:260-71.
11. Leigh J, Driscoll T. Malignant mesothelioma in Australia; 1945-2002. Int J Occup Environ Health 2003;9:206-17.
12. Edge JR. Incidence of bronchial carcinoma in shipyard workers with pleural plaques. Ann NY Acad Sci 1979;330:289-99.
13. Butchart EG, Ashcroft T, Barnsley WC, Holden MP. Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients. Thorax 1976;31:15-24.
14. Grondin SC, Sugarbaker DJ. Pleuropneumonectomy in the treatment of malignant mesothelioma. Chest 1999;116(Suppl):4505-45.
15. Wang ZJ, Reddy GP, Gotway MB, Higgins CB, Jablons DM, Ramaswamy M, et al. Malignant pleural mesothelioma: evaluation with CT, MR imaging, and PET. Radiographics 2004;24:105-19.
16. Pilling JE, Stewart DJ, Martin-Ucar AE, Muller S, O'Byrne KJ, Waller DA. The case for routine cervical mediastinotomy prior to radical surgery for malignant pleural mesothelioma. Eur J Cardio-thorac Surg 2004;25:497-5.
17. Hahn SM, Smith RP, Friedberg J. Photodynamic therapy for mesothelioma. Curr Treat Options Oncol 2001;2:375-83.
18. Ahamad A, Stevens CW, Smythe WR, Vaporciyan AA, Komaki R, Kelly JF, et al. Intensity-modulated radiation therapy: a novel approach to the management of malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 2003;55:768-75.
19. Ordonez NG. Value of mesothelin immunostaining in the diagnosis of mesothelioma. Mod Pathol 2003;16:192-7.